Strata Critical Medical, Inc. Class A Common Stock SRTA Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $67.38M+87.4% | $66.79M+83.5% | $49.3M+36.7% | $70.8M+4.2% | $35.95M-30.2% | ||
| $53.27M+84.3% | $55.12M+75.7% | $37.68M+32.0% | $53.06M+2.9% | $28.9M-30.2% | ||
| $14.12M+100% | $11.67M+133% | $11.61M+54.7% | $17.74M+8.5% | $7.05M-30.4% | ||
| 21%+1.3pp | 17.5%+3.7pp | 23.6%+2.7pp | 25.1%+1.0pp | 19.6%-0.1pp | ||
| $15.61M+26.6% | —— | —— | —— | $12.33M-3.0% | ||
| $1.49M+264% | $3.01M+856% | $1.7M+442% | $1.78M+465% | $408K+29.7% | ||
| $17.09M+34.2% | —— | —— | —— | $12.74M-2.2% | ||
| $17.09M+34.2% | —— | —— | —— | $12.74M-2.2% | ||
| -$2.97M+47.7% | -$6.41M-8.5% | -$5.62M+20.7% | -$4.95M+59.2% | -$5.69M+42.4% | ||
| -4.4%+11.4pp | -9.6%+6.6pp | -11.4%+8.3pp | -7%+10.9pp | -15.8%+3.3pp | ||
| $473K-64.2% | $638K-59.9% | $1.13M-36.1% | $1.16M-35.4% | $1.32M-36.2% | ||
| $5.38M+32.0% | $1.02M— | -$4.04M-375% | $1.23M+40.8% | $4.07M-26.6% | ||
| $2.4M+249% | -$5.39M+27.5% | -$9.66M-71.6% | -$3.72M+67.0% | -$1.61M+62.7% | ||
| $0— | $0— | $0— | $21K-59.6% | $0+100% | ||
| $2.15M+162% | —— | $57.42M+3,038% | -$3.74M+67.0% | -$3.49M+17.5% | ||
| 3.2%+12.9pp | —— | 116.5%+122pp | -5.3%+11.4pp | -9.7%-1.5pp | ||
| $0.03+250% | -$5,388,000.00+27.5% | -$9,657,000.00-71.6% | -$5,020,999.98— | -$0.02— | ||
| $0.00+100% | —— | $0.81+1,520% | —— | -$0.02— | ||
| $0.03+175% | —— | $0.70+2,433% | -$0.05+66.7% | -$0.04+33.3% | ||
| $0.03+175% | —— | $0.70+2,433% | -$0.05+66.7% | -$0.04+33.3% | ||
| 90.2M+12.9% | 82.1M+5.9% | 82.5M+5.7% | 81.3M+4.8% | 79.9M+5.4% | ||
| 85.3M+6.8% | 82.1M+5.9% | 82.5M+5.7% | 81.3M+4.8% | 79.9M+5.4% | ||
| -$3.44M— | —— | —— | —— | $0— | ||
| $473K-64.2% | $638K-59.9% | $1.13M-36.1% | $1.16M-35.4% | $1.32M-36.2% | ||
| $0.03+250% | -$0.06+40.0% | -$0.12-71.4% | -$0.04— | -$0.02— | ||
| $0.03+250% | -$0.06+40.0% | -$0.12-71.4% | -$0.04— | -$0.02— | ||
| $1.49M+264% | —— | —— | —— | $408K+29.7% | ||
| $2.4M+249% | -$5.39M+27.5% | -$9.66M-71.6% | -$3.41M— | -$1.61M— | ||
| $67.38M+87.4% | $66.79M+83.5% | $49.3M+36.7% | $70.8M+4.2% | $35.95M-30.2% | ||
| -$2.97M+47.7% | -$6.41M-8.5% | -$5.62M+20.7% | -$4.95M+59.2% | -$5.69M+42.4% | ||
| $86K+102% | -$3.4M+22.3% | -$3.92M+32.6% | -$3.18M+70.0% | -$3.99M+51.8% | ||
| $86K+102% | -$3.4M+22.3% | -$3.92M+32.6% | -$3.18M+70.0% | -$3.99M+51.8% | ||
| 0.1%+11.2pp | -5.1%+6.9pp | -7.9%+8.2pp | -4.5%+11.1pp | -11.1%+5.0pp | ||
| -$2.97M+47.7% | -$6.41M-8.5% | -$5.62M+20.7% | -$4.95M+59.2% | -$5.69M+42.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Strata Critical Medical, Inc. Class A Common Stock's revenue?
- Strata Critical Medical, Inc. Class A Common Stock (SRTA) generated $254.3M in revenue over the trailing twelve months, up 44.2% year over year.
- Is Strata Critical Medical, Inc. Class A Common Stock profitable?
- Strata Critical Medical, Inc. Class A Common Stock reported $52.3M in net income over the trailing twelve months, a 21.0% net margin.
- What are Strata Critical Medical, Inc. Class A Common Stock's profit margins?
- Gross margin is 21.7% and operating margin is -7.8%, with a 21.0% net margin.
- What is Strata Critical Medical, Inc. Class A Common Stock's earnings per share?
- Strata Critical Medical, Inc. Class A Common Stock's diluted EPS over the trailing twelve months is $0.64.
- Where does Strata Critical Medical, Inc. Class A Common Stock's income statement data come from?
- Every line is extracted from Strata Critical Medical, Inc. Class A Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
